Erratum: Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes (Leukemia (2013) 27 (2112))

M. M. Patnaik, E. Padron, R. R. Laborde, T. L. Lasho, C. M. Finke, C. A. Hanson, J. M. Hodnefield, R. A. Knudson, R. P. Ketterling, A. Al-Kali, A. Pardanani, N. A. Ali, R. S. Komrokji, A. Tefferi

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalLeukemia
Volume27
Issue number10
DOIs
StatePublished - Oct 1 2013

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Patnaik, M. M., Padron, E., Laborde, R. R., Lasho, T. L., Finke, C. M., Hanson, C. A., Hodnefield, J. M., Knudson, R. A., Ketterling, R. P., Al-Kali, A., Pardanani, A., Ali, N. A., Komrokji, R. S., & Tefferi, A. (2013). Erratum: Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes (Leukemia (2013) 27 (2112)). Leukemia, 27(10). https://doi.org/10.1038/leu.2013.229